Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Bacterial DNA and DNA-dependent enzymes" collectively refers to a group of **enzymes in bacteria responsible for the metabolism of DNA**, including replication, repair, recombination, and transcription. Notable enzymes in this group include **DNA polymerases** (which synthesize new DNA strands and are essential for genome duplication)[5][7], **DNA ligases** (which seal breaks in the DNA backbone during replication and repair, utilizing either NAD^+^ or ATP as a cofactor)[1][2][4][6], **DNA topoisomerases** (which manage DNA supercoiling and untangling), and **RNA polymerase** (which transcribes DNA into RNA for gene expression)[3]. These enzymes are fundamental for bacterial survival and genomic maintenance. Many of them serve as **therapeutic targets for antibiotics**, such as rifampicin (which inhibits bacterial RNA polymerase) and fluoroquinolones (which inhibit bacterial DNA gyrase/topoisomerase). Some, like NAD^+^-dependent DNA ligases, are essential for bacterial viability and have been studied as potential antibiotic targets[6]. The various classes of these enzymes can possess different functions in distinct bacterial species and may localize to different cellular compartments. The term is **overly broad** as a therapeutic target and does not specify a single molecule, but rather a functionally related group of essential bacterial enzymes, each of which can be targeted individually by specific drugs[1][5][3][6][4][7].\n\n**Note:**\n- The target name as given is **not standard, highly non-specific, and represents a functional group rather than a discrete molecular entity**. Every bacterial species encodes multiple, distinct DNA-dependent enzymes, each with unique biochemical properties, druggability, and roles in physiology/disease[1][2][4][5][6][3][7].\n- For structured data or drug discovery purposes, it is critical to reference and classify each **individual enzyme** (e.g., "Bacterial DNA gyrase subunit A", "Bacterial NAD^+^-dependent DNA ligase", "Bacterial multisubunit RNA polymerase", etc.) rather than the generic category "Bacterial DNA and DNA-dependent enzymes."\n\n**Summary (as requested for structured extraction):**\n- The input target is **too broad, not a single canonical molecule, and should be replaced by more specific enzyme targets**.\n- Nevertheless, many essential bacterial DNA-dependent enzymes (polymerases, ligases, RNA polymerase, etc.) are validated therapeutic targets for antibacterial drugs.
Inhibition of DNA replication (by targeting DNA polymerases)[7][5]; Inhibition of DNA repair (by targeting DNA ligases, polymerases, topoisomerases)[6][1][2][4]; Inhibition of transcription (by targeting bacterial RNA polymerase)[3]; DNA strand breakage or inhibition of DNA joining (by targeting DNA ligases)[1][2][4][6]
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA and DNA-dependent enzyme.